登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688466 证券简称：金科环境 公告编号：2026-003 金科环境股份有限公司 关于《锡东工业污水处理项目特许经营协议》终止 的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 重点内容提示： ● 金科环境股份有限公司（以下简称"公司"）实施的锡东工业污水处理项目因公司向园区排污企业收取 的污水处理费未能保证项目连续三个月正常运转和投资收益要求，触发各方于2023年签署的《锡东工业 污水处理项目特许经营协议》（以下简称"《特许经营协议》"）中项目回购约定情形。相关方于2025年 12月签订《锡东工业污水处理项目特许经营终止协议》（以下简称"《终止协议》"），特许经营权终止 日为2025年3月31日。近日，公司控股子公司无锡市锡山荷泰污水处理有限公司（以下简称"项目公 司"或"锡山荷泰"）与锡山经济技术开发区管理委员会（以下简称"锡山经开区管委会"）指定主体无锡 云隆园区建设发展有限公司（以下简称"无锡云隆"）签订《锡东工业污水处理厂项目回购协议》（以下 ...

Core Viewpoint - The company, ZhenDe Medical, has decided to cancel repurchased shares and reduce its registered capital, impacting its total share capital and registered capital amounts. Group 1: Share Repurchase and Capital Reduction - The company will cancel a total of 1,959,310 shares, which includes 129,442 shares already repurchased and 1,829,868 shares from the second phase of the employee stock ownership plan that have not been unlocked. This change will alter the total share capital from 265,835,535 shares to 263,876,225 shares and reduce the registered capital from 265,835,535 yuan to 263,876,225 yuan [1][2]. Group 2: Notification to Creditors - Creditors are notified that they have 30 days from receiving the notice, or 45 days from the announcement date if no notice is received, to claim their debts or request guarantees. Failure to act within this timeframe will not affect the validity of their claims, and the company will continue to fulfill its obligations as per the original debt agreements [2]. Group 3: Debt Claim Submission Requirements - Creditors must provide original and copies of documents proving the existence of the debt relationship when submitting claims. Legal entities must also present their business license and identification of their legal representative, while individuals must provide valid identification [3]. Group 4: Debt Claim Submission Methods - Claims can be submitted in person, by mail, or via email. The submission period starts from February 10, 2026, and lasts for 45 days. Contact details for submissions include a physical address, phone number, and email [4][5].

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：605069 证券简称：正和生态 公告编号：2026-005 北京正和恒基滨水生态环境治理股份有限公司 首次公开发行部分限售股上市流通公告 经中国证券监督管理委员会证监许可[2021]2490号文《关于核准北京正和恒基滨水生态环境治理股份有 限公司首次公开发行股票的批复》核准，北京正和恒基滨水生态环境治理股份有限公司（以下简称"本 公司"或"正和生态"）公开发行人民币普通股股票4,071.1111万股，并于2021年8月16日在上海证券交易 所挂牌上市。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 本次上市流通的限售股为公司首次公开发行股票形成的部分限售股，共计127,536,500股，涉及股东共计 3名，限售期为自公司股票上市之日起36个月，已于2024年8月15日届满。 重要内容提示： ● 本次股票上市类型为首发股份；股票认购方式为网下，上市股数为127,536,500股。 本次股票上市流通总数为127,536,500股。 ● 本次股票上市流通日期为202 ...

证券代码：600956 证券简称：新天绿能 公告编号：2026-002 新天绿色能源股份有限公司 关于董事会秘书离任 截至本公告日，班泽锋先生直接持有公司H股股票5万股，及依据公司2023年A股限制性股票激励计划已 授予但尚未解除限售的A股限制性股票20万股。辞职后，班泽锋先生将严格遵守《上市公司董事和高级 管理人员所持本公司股份及其变动管理规则》《上海证券交易所上市公司自律监管指引第15号一一股东 及董事、高级管理人员减持股份》及其他有关股份买卖的限制性规定，其所持有的A股限制性股票将依 照《上市公司股权激励管理办法》《新天绿色能源股份有限公司2023年A股限制性股票激励计划》等相 关规定，后续尽快办理回购注销手续。回购手续完成前，班泽锋先生将继续遵守作为激励对象所作出的 承诺。 二、离任对公司的影响 根据《公司法》《上海证券交易所股票上市规则》等有关规定，班泽锋先生的辞职报告自送达董事会之 日起生效，其辞职后将不再继续在公司担任其他职务。班泽锋先生所负责的工作已按照公司相关规定妥 善交接，除作为公司2023年A股限制股票激励对象所作出的承诺外，不存在其他应当履行而未履行的承 诺，其离任不会对公司的正常经营 ...

Core Viewpoint - The company held its first extraordinary general meeting of shareholders in 2026, where all proposed resolutions were approved without any objections [2][4]. Group 1: Meeting Details - The extraordinary general meeting was held on February 9, 2026, at the company's conference room located in Beijing [2]. - The meeting was convened by the board of directors and chaired by Chairman Wang Wei, utilizing a combination of on-site and online voting methods [2][3]. Group 2: Attendance - All nine current directors attended the meeting, along with the company’s vice president and board secretary, Yin Shi, and other senior management and witnessing lawyers [3]. Group 3: Resolutions Reviewed - A total of 23 resolutions were presented, all of which were approved, including: - Issuing shares to purchase assets and raising matching funds, which complies with relevant laws and regulations [4][8]. - Specific plans regarding the issuance of shares for asset purchases, including transaction prices, payment methods, and types of shares [5][6]. - Approval of the asset purchase agreement and related documents, including a profit compensation agreement [8][10]. Group 4: Voting and Legal Compliance - The resolutions were categorized as special resolutions, requiring more than two-thirds approval from the shares represented at the meeting [10]. - The company’s controlling shareholder, China Development Investment Group, which holds 44.57% of the total shares, abstained from voting on related resolutions [10]. - The meeting was witnessed by Beijing Jindu Law Firm, which confirmed that the meeting complied with relevant laws and regulations [10].

Group 1 - The core point of the announcement is the change in the shareholding structure of the controlling shareholder, Guangzhou Light Industry Trade Group Co., Ltd. (Light Industry Group) [1] - Before the change, Guangzhou Municipal Government held 90.03% of Light Industry Group, while Guangdong Provincial Department of Finance held 9.97%. After the change, Guangzhou Municipal Government holds 57.03%, Guangzhou Industrial Investment Holding Group Co., Ltd. (Guangzhou Investment) holds 33%, and Guangdong Provincial Department of Finance retains 9.97% [1] - The change in the shareholding structure does not affect the controlling shareholder or the actual controller of the company, which remains Light Industry Group and Guangzhou Municipal Government, respectively [2] Group 2 - The change in the shareholding structure does not impact Guangzhou Investment's direct shareholding in the company, which remains at 89,256,197 shares, accounting for 4.86% of the total share capital [2] - The company emphasizes that the change will not have a significant impact on its normal production and operational activities [2]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688098 证券简称：申联生物 公告编号：2026-004 申联生物医药(上海)股份有限公司 关于持股5%以上股东权益变动触及1%刻度及减持计划完成暨减持股份结果公告 信息披露义务人UNITED BIOMEDICAL,INC.保证向本公司提供的信息真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏，并对其真实性、准确性和完整性依法承担法律责任。本公司董事会及全体 董事保证公告内容与信息披露义务人提供的信息一致。 重要内容提示： ● 股东持股的基本情况 本次减持计划实施前，美国联合生物医药公司（UNITED BIOMEDICAL,INC.以下简称"UBI"）持有申 联生物医药（上海）股份有限公司（以下简称"公司"或"申联生物"）43,199,898股股份，占公司总股本 的10.52%。上述股份来源为公司首次公开发行股票并上市前取得，且已于2020年10月28日后上市流 通。 ● 减持计划的实施结果情况 本次权益变动为UBI履行此前披露的减持股份计划所致，不触及要约收购。本次权益变动不会导致公司 控股股东、实际控制人发生变化，不会对公司治理结构及未 ...

国盛证券有色金属首席分析师张航对上海证券报记者表示，最新公布的1月美国ADP新增就业人数仅为 2.2万人，低于前值4.1万人，且远低于市场预期值。尽管同期制造业PMI回到52.6%的荣枯线上，但美国 就业市场依然偏弱，市场密切关注后续美国非农数据的发布。 此外，贵金属实物需求或依然强劲。各国央行持续在小规模购入黄金。根据央行2月7日发布的数据，截 至1月末，我国黄金储备达7419万盎司，环比增加4万盎司，实现连续第15个月增持黄金。同时，全球资 金配置白银的意愿也在回升，全球最大的白银ETF（SLV）在2月3日单日增持1000吨，为历史上第三大 单日增幅纪录，显示中长线资金对贵金属后市的积极预期。 尽管贵金属价格近日回升，但面对即将到来的春节假期，国内投资者的态度仍较为谨慎，都在琢磨同一 件事：要不要持仓过节？ 张峻滔认为，目前金价仍处在上行试探区间，预计接近前高时将面临短期阻力。鉴于今年春节假期较 长，建议投资者可借当前反弹契机适度减仓，等待节后更明确的买入机会。 贵金属在"高台跳水"后逐渐回升，黄金重新收复5000美元/盎司关键关口。 截至北京时间2月9日19时30分许，伦敦现货黄金（下称"伦敦金"）已回 ...

Core Viewpoint - The company has announced a change in its signing registered accountants due to internal adjustments within the auditing firm, which will not adversely affect the financial statements and internal control audits for the year 2025 [1][4]. Group 1: Change of Signing Registered Accountants - The company has appointed Yu Guohui and Sun Jianfei as the new signing registered accountants, replacing Chu Shiwei and Wang Qing due to their work adjustments [1][2]. - Yu Guohui has been a certified public accountant since 2012 and has experience in auditing listed companies since 2010, having signed audit reports for several companies in the past three years [2]. - Sun Jianfei became a certified public accountant in 2026 and has been involved in auditing listed companies since 2018 [2]. Group 2: Integrity and Independence - Both Yu Guohui and Sun Jianfei have no violations of independence requirements as per the relevant accounting standards and have not faced any criminal or administrative penalties in the last three years [3]. Group 3: Impact of the Change - The change in signing registered accountants is a result of internal adjustments within the auditing firm, and the transition has been orderly, ensuring no negative impact on the company's financial reporting and internal control audits for 2025 [4].

登录新浪财经APP 搜索【信披】查看更多考评等级 重要内容提示： 截至2026年2月9日收市后，距离2月10日（"华正转债"最后交易日，含当日）仅剩1个交易日，2月10日 为"华正转债"最后一个交易日。 ● 最后转股日：2026年2月13日 截至2026年2月9日收市后，距离2月13日（"华正转债"最后转股日，含当日）仅剩4个交易日，2月13日 为"华正转债"最后一个转股日。 ● 本次提前赎回完成后，"华正转债"将自2026年2月24日起在上海证券交易所摘牌。 ● 投资者所持"华正转债"除在规定时限内通过二级市场继续交易或按照38.51元/股的转股价格进行转股 外，仅能选择以100元/张的票面价格加当期应计利息（即100.1529元/张）被强制赎回。若被强制赎回， 可能面临较大投资损失。 证券代码：603186 证券简称：华正新材 公告编号2026-012 转债代码：113639 转债简称：华正转债 浙江华正新材料股份有限公司关于实施"华正转债"赎回暨摘牌的第五次提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担个别及连带责任。 ...